4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, which is authorised and regulated by the Financial Conduct Authority, register number 775193
© 2015-2019 by 4BIO Ventures Management Ltd

Data suggest gene, cell therapy trial initiations in Europe lag behind North America — here's why

November 1, 2019

4BIO's Dmitry Kuzmin and Owen Smith enjoyed speaking to Natalie Grover at Endpoints on the state of cell & gene therapy trials in Europe and the US following yesterday’s report from the Alliance for Regenerative Medicine. We also discussed the trends 4BIO expects to see as more treatments are developed.

 

 

Read at Endpoints: https://endpts.com/gene-cell-therapy-trial-initiations-in-europe-lag-behind-north-america-study-finds/

Please reload

ARCHIVE
Please reload

SEARCH BY TAGS
Please reload

FOLLOW US